Are You Waiting for Opioid Settlement Money From Purdue, Mallinckrodt or Endo? Get in Touch.

ProPublica and The Philadelphia Inquirer are soliciting firsthand accounts from opioid victims awaiting compensation from court-appointed trusts funded by Purdue Pharma, Mallinckrodt, and Endo, as part of an investigation into how individual claimants have fared under settlement agreements. The reporting is authored by named journalists with established track records covering opioid litigation and corporate malfeasance (Craig McCoy and Bob Fernandez, both formerly of the Inquirer), and ProPublica's prior coverage has documented that fewer than half of nearly 140,000 claims filed against Purdue will receive compensation—a substantive framing that contextualizes the callout. Independent coverage from Reuters, PBS, and The Guardian corroborates the broader settlement landscape, including recent judicial delays in Purdue's criminal sentencing to allow victim participation, and confirms the scale of the Sackler family's financial obligations across state, local, tribal, and individual victim payouts. Critical readers should monitor the outcomes of the criminal sentencing proceeding and any changes to claim-distribution procedures that may emerge from investigative findings.